Churg-Strauss syndrome (patient information): Difference between revisions

Jump to navigation Jump to search
Line 4: Line 4:


==Overview==
==Overview==
[[Eosinophilic granulomatosis with polyangiitis]] previously called [[Eosinophilic granulomatosis with polyangiitis|Churg-Strauss syndrome]] is a small and medium-sized necrotizing [[vasculitis]], with extravascular [[granuloma]] formation. The disease was first described by Churg and Strauss in 1951. The [[etiology]] is not known. However, various environmental factors, [[Allergen|allergens]], [[genetics]], and [[:Category:Drugs|drugs]] may play a role in triggering [[disease]] process by activating [[Eosinophil granulocyte|eosinophils]], [[B cell|B]] and [[T cell|T lymphocytes]] and [[Macrophage|macrophages]]. The disease is characterized by the presence of [[asthma]], peripheral [[eosinophilia]], [[rhinosinusitis]], [[peripheral neuropathy]] and multiple [[Organ (anatomy)|organ]] involvements including [[skin]], [[Gastrointestinal tract|GI tract]], and [[kidney]].


==What are the symptoms of Churg-Strauss syndrome?==
==What are the symptoms of Churg-Strauss syndrome?==

Revision as of 18:12, 12 April 2018

Churg-Strauss syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Churg-Strauss syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Churg-Strauss syndrome (patient information) On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Churg-Strauss syndrome (patient information)

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Churg-Strauss syndrome (patient information)

CDC on Churg-Strauss syndrome (patient information)

Churg-Strauss syndrome (patient information) in the news

Blogs on Churg-Strauss syndrome (patient information)

Directions to Hospitals Treating Churg-Strauss syndrome

Risk calculators and risk factors for Churg-Strauss syndrome (patient information)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Eosinophilic granulomatosis with polyangiitis previously called Churg-Strauss syndrome is a small and medium-sized necrotizing vasculitis, with extravascular granuloma formation. The disease was first described by Churg and Strauss in 1951. The etiology is not known. However, various environmental factors, allergensgenetics, and drugs may play a role in triggering disease process by activating eosinophilsB and T lymphocytes and macrophages. The disease is characterized by the presence of asthma, peripheral eosinophiliarhinosinusitisperipheral neuropathy and multiple organ involvements including skinGI tract, and kidney.

What are the symptoms of Churg-Strauss syndrome?

What causes Churg-Strauss syndrome?

Who is at highest risk?

Diagnosis

When to seek urgent medical care?

Treatment Options

Where to find medical care for Churg-Strauss syndrome

Prevention

What to expect (Outlook/Prognosis)?

Possible Complications

Sources

References

Template:WH Template:WS